Aza- indolyl derivatives for treating obesity
US6583134B2 · kind B2 · utility
0Cited by
9References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 27, 2001 |
| Grant date | Jun 24, 2003 |
| Priority date | — |
| Expiry date | Feb 27, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds of formula (I): wherein X1, X2, X3 and X4, n, R1, R2 and R3 are defined in the specification, and pharmaceutically acceptable salts and prodrugs of the compounds of formula (I) have therapeutic uses. These compounds are useful for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea. They are particularly useful for the treatment of obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.